DOI: 10.1055/s-00033990

TH Open

References

Young G, Liesner R, Chang T. et al.
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors.

Blood 2019;
134 (24) 2127-2138

Download Bibliographical Data

Access: